NYU Langone Psychedelic Medicine Program
Address: 423 E 23rd St, New York, NY 10010
Hours: Trial enrollment by application
About NYU Langone Psychedelic Medicine Program
Michael Bogenschutz's group at NYU Langone led the landmark psilocybin alcohol use disorder RCT (published JAMA Psychiatry 2022) — the most rigorous clinical trial of psilocybin for substance use disorder to date. Also known for palliative care and cancer anxiety research. Currently running follow-up alcohol trials and expanding to other indications.
Location & Legal Context
NYU Langone Psychedelic Medicine Program operates in New York. Before visiting or purchasing, review the psilocybin laws in New York to understand the current legal landscape.
Community Reviews
Community reviews coming in Phase 2. Have you worked with NYU Langone Psychedelic Medicine Program? Share your experience in the forum.